内镜黏膜下剥离术对巴雷特食管可见肿瘤组织学诊断的影响
这项多中心前瞻性队列研究纳入205例巴雷特食管可见肿瘤患者,评估内镜黏膜下剥离术(ESD)相比术前组织学改变诊断的频率与因素。ESD使55.1%病例的组织学诊断发生改变,其中68.1%升级、31.9%降级;23.9%升级为浸润性癌。远端食管及胃食管交界处病变和既往射频消融是诊断改变的预测因素。
要点
- ESD改变了55.1%(113/205)巴雷特食管可见肿瘤患者的组织学诊断。
- 诊断改变中68.1%为升级、31.9%为降级,23.9%升级为浸润性癌。
- 远端食管及胃食管交界处病变和既往射频消融是诊断改变的预测因素。
核心结论
- ESD使超过半数巴雷特食管可见肿瘤患者的诊断发生改变,选择性ESD可作为潜在的诊断和分期工具,尤其适用于疑似浸润性疾病患者。
研究设计与样本
- 多中心前瞻性队列研究,纳入2016年至2021年因巴雷特食管可见肿瘤接受ESD的205例患者,中位年龄69岁,81%为男性。
- 基线组织学通过活检钳获取(n=182)或内镜黏膜切除术获取(n=23)。
主要发现
- ESD使55.1%(113/205)病例的组织学诊断发生改变,其中68.1%为升级、31.9%为降级。
- 基线组织学用活检钳获取者诊断改变频率为55.5%,用内镜黏膜切除术获取者为52.2%(P=.83)。
- 23.9%(49/205)病例经ESD组织病理学升级为浸润性癌。
- 多因素分析显示,远端食管及胃食管交界处病变(比值比2.1;95%CI 1.1-3.9;P=.02)和既往射频消融(比值比2.5;95%CI 1.2-5.5;P=.02)是组织学诊断改变的预测因素。
临床怎么用
- 作者认为,选择性ESD可作为潜在的诊断和分期工具,尤其适用于疑似浸润性疾病患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Data are limited on the role of endoscopic submucosal dissection (ESD) as a potential diagnostic and staging tool in Barrett's esophagus (BE) neoplasia. We aimed to evaluate the frequency and factors associated with change of histologic diagnosis by ESD compared with pre-ESD histology. METHODS: This was a multicenter, prospective cohort study of patients who underwent ESD for BE visible neoplasia. A change in histologic diagnosis was defined as "upstaged" or "downstaged" if the ESD specimen had a higher or lower degree, respectively, of dysplasia or neoplasia when compared with pre-ESD specimens. RESULTS: Two hundred five patients (median age, 69 years; 81% men) with BE visible neoplasia underwent ESD from 2016 to 2021. Baseline histology was obtained using forceps (n = 182) or EMR (n = 23). ESD changed the histologic diagnosis in 55.1% of cases (113/205), of which 68.1% were upstaged and 31.9% downstaged. The frequency of change in diagnosis after ESD was similar whether baseline histology was obtained using forceps (55.5%) or EMR (52.2%) (P = .83). In aggregate, 23.9% of cases (49/205) were upstaged to invasive cancer on ESD histopathology. On multivariate analysis, lesions in the distal esophagus and gastroesophageal junction (odds ratio, 2.1; 95 confidence interval, 1.1-3.9; P = .02) and prior radiofrequency ablation (odds ratio, 2.5; 95% confidence interval, 1.2-5.5; P = .02) were predictors of change in histologic diagnosis. CONCLUSIONS: ESD led to a change of diagnosis in more than half of patients with BE visible neoplasia. Selective ESD can serve as a potential diagnostic and staging tool, particularly in those with suspected invasive disease. (Clinical trial registration number: NCT02989818.).
引用
- Yang D, King W, Aihara H, et al. Effect of endoscopic submucosal dissection on histologic diagnosis in Barrett's esophagus visible neoplasia. Gastrointest Endosc. 2021. PMID: 34906544. doi:10.1016/j.gie.2021.11.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。